DE69130381T2 - Oligomere, ihre Verwendungen sowie Formulierungen - Google Patents

Oligomere, ihre Verwendungen sowie Formulierungen

Info

Publication number
DE69130381T2
DE69130381T2 DE69130381T DE69130381T DE69130381T2 DE 69130381 T2 DE69130381 T2 DE 69130381T2 DE 69130381 T DE69130381 T DE 69130381T DE 69130381 T DE69130381 T DE 69130381T DE 69130381 T2 DE69130381 T2 DE 69130381T2
Authority
DE
Germany
Prior art keywords
oligomers
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69130381T
Other languages
English (en)
Other versions
DE69130381D1 (de
Inventor
Alan D Cardin
Richard L Jackson
Michael J Mullins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Chemical Co
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc, Dow Chemical Co filed Critical Merrell Dow Pharmaceuticals Inc
Publication of DE69130381D1 publication Critical patent/DE69130381D1/de
Application granted granted Critical
Publication of DE69130381T2 publication Critical patent/DE69130381T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/41—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton
    • C07C309/42—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton having the sulfo groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/45—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/51—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/12—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from polycarboxylic acids and polyhydroxy compounds
    • C08G63/16—Dicarboxylic acids and dihydroxy compounds
    • C08G63/18—Dicarboxylic acids and dihydroxy compounds the acids or hydroxy compounds containing carbocyclic rings
    • C08G63/19—Hydroxy compounds containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/68—Polyesters containing atoms other than carbon, hydrogen and oxygen
    • C08G63/688—Polyesters containing atoms other than carbon, hydrogen and oxygen containing sulfur
    • C08G63/6884—Polyesters containing atoms other than carbon, hydrogen and oxygen containing sulfur derived from polycarboxylic acids and polyhydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/68—Polyesters containing atoms other than carbon, hydrogen and oxygen
    • C08G63/692—Polyesters containing atoms other than carbon, hydrogen and oxygen containing phosphorus
    • C08G63/6924—Polyesters containing atoms other than carbon, hydrogen and oxygen containing phosphorus derived from polycarboxylic acids and polyhydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G64/00—Macromolecular compounds obtained by reactions forming a carbonic ester link in the main chain of the macromolecule
    • C08G64/04—Aromatic polycarbonates
    • C08G64/06—Aromatic polycarbonates not containing aliphatic unsaturation
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G64/00—Macromolecular compounds obtained by reactions forming a carbonic ester link in the main chain of the macromolecule
    • C08G64/04—Aromatic polycarbonates
    • C08G64/06—Aromatic polycarbonates not containing aliphatic unsaturation
    • C08G64/08—Aromatic polycarbonates not containing aliphatic unsaturation containing atoms other than carbon, hydrogen or oxygen
    • C08G64/081—Aromatic polycarbonates not containing aliphatic unsaturation containing atoms other than carbon, hydrogen or oxygen containing sulfur
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G64/00—Macromolecular compounds obtained by reactions forming a carbonic ester link in the main chain of the macromolecule
    • C08G64/04—Aromatic polycarbonates
    • C08G64/06—Aromatic polycarbonates not containing aliphatic unsaturation
    • C08G64/08—Aromatic polycarbonates not containing aliphatic unsaturation containing atoms other than carbon, hydrogen or oxygen
    • C08G64/083—Aromatic polycarbonates not containing aliphatic unsaturation containing atoms other than carbon, hydrogen or oxygen containing phosphorus
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/26—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from polyamines and polycarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/26—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from polyamines and polycarboxylic acids
    • C08G69/32—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from polyamines and polycarboxylic acids from aromatic diamines and aromatic dicarboxylic acids with both amino and carboxylic groups aromatically bound
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G71/00—Macromolecular compounds obtained by reactions forming a ureide or urethane link, otherwise, than from isocyanate radicals in the main chain of the macromolecule
    • C08G71/02—Polyureas
DE69130381T 1990-07-09 1991-07-08 Oligomere, ihre Verwendungen sowie Formulierungen Expired - Fee Related DE69130381T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54978290A 1990-07-09 1990-07-09
US07/710,370 US5276182A (en) 1990-07-09 1991-06-10 Process for preparing polyurea oligomers

Publications (2)

Publication Number Publication Date
DE69130381D1 DE69130381D1 (de) 1998-11-26
DE69130381T2 true DE69130381T2 (de) 1999-03-11

Family

ID=27069228

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69130381T Expired - Fee Related DE69130381T2 (de) 1990-07-09 1991-07-08 Oligomere, ihre Verwendungen sowie Formulierungen
DE69129410T Expired - Fee Related DE69129410T2 (de) 1990-07-09 1991-07-08 Oligomere mit wirkung gegen herpes- und zytomegaliviren

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69129410T Expired - Fee Related DE69129410T2 (de) 1990-07-09 1991-07-08 Oligomere mit wirkung gegen herpes- und zytomegaliviren

Country Status (27)

Country Link
US (9) US5276182A (de)
EP (2) EP0538373B1 (de)
JP (2) JP3442072B2 (de)
KR (2) KR100212336B1 (de)
CN (1) CN1051096C (de)
AP (1) AP287A (de)
AT (2) ATE165974T1 (de)
AU (2) AU650281B2 (de)
CA (2) CA2086438C (de)
CZ (1) CZ288574B6 (de)
DE (2) DE69130381T2 (de)
DK (2) DK0467185T3 (de)
EG (1) EG19652A (de)
ES (2) ES2116295T3 (de)
FI (2) FI108041B (de)
HK (1) HK1009280A1 (de)
HU (2) HU214876B (de)
IE (1) IE912375A1 (de)
IL (1) IL98761A (de)
MX (1) MX9100123A (de)
NO (2) NO302827B1 (de)
NZ (1) NZ238847A (de)
OA (1) OA10045A (de)
PT (1) PT98255B (de)
RU (1) RU2102406C1 (de)
SK (1) SK283655B6 (de)
WO (1) WO1992000749A1 (de)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670144A (en) * 1990-07-09 1997-09-23 Merrell Pharmaceuticals Inc. Anti-herpes virus and cytomegalovirus polyester oligomers
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers
US5312837A (en) * 1991-01-29 1994-05-17 Genelabs Technologies, Inc. Method of treating viral infections with aryl macrocyclic compounds
ATE116637T1 (de) * 1991-02-05 1995-01-15 Merrell Dow Pharma Sulfonische stilbenderivate zur behandlung von viruserkrankungen.
US5424063A (en) * 1992-01-09 1995-06-13 The Dow Chemical Company Narrow poly- and mono-dispersed anionic oligomers, and their uses, formulations and process
US5217469A (en) * 1992-01-27 1993-06-08 Moshe Dolev Rotary head spring-loaded tweezer hair removal device
KR100275843B1 (ko) * 1992-02-20 2000-12-15 슈테펜엘.네스비트 설폰산 유도체 및 이를 포함하는 약제학적 조성물
WO1993023569A1 (en) * 1992-05-11 1993-11-25 Ribozyme Pharmaceuticals, Inc. Method and reagent for inhibiting viral replication
US5972699A (en) * 1992-05-14 1999-10-26 Ribozyme Pharmaceuticals, Inc. Method and reagent for inhibiting herpes simplex virus replication
US5460807A (en) * 1992-08-19 1995-10-24 Merrell Dow Pharmaceuticals Inc. Antiproliferative oligomers
JPH08500590A (ja) * 1992-08-19 1996-01-23 メレルダウファ−マス−ティカルズ インコーポレイテッド 抗血管形成オリゴマー類
AU670962B2 (en) * 1992-09-28 1996-08-08 Merrell Dow Pharmaceuticals Inc. Method for antagonizing inositol 1,4,5-triphosphate
US5384119A (en) * 1993-08-12 1995-01-24 Merrell Dow Pharmaceuticals Inc. Method of preventing neutrophil mediated connective tissue damage
IL112174A (en) * 1994-01-03 1999-05-09 Merrell Dow Pharma Oligomers of polythioureas pharmaceutical compositions containing them and a process for their preparation
US5780483A (en) * 1995-02-17 1998-07-14 Smithkline Beecham Corporation IL-8 receptor antagonists
EP0809492A4 (de) * 1995-02-17 2007-01-24 Smithkline Beecham Corp Il-8 rezeptor antagonisten
US6005008A (en) * 1996-02-16 1999-12-21 Smithkline Beecham Corporation IL-8 receptor antagonists
US6262113B1 (en) 1996-03-20 2001-07-17 Smithkline Beecham Corporation IL-8 receptor antagonists
US6211373B1 (en) 1996-03-20 2001-04-03 Smithkline Beecham Corporation Phenyl urea antagonists of the IL-8 receptor
HUP9903922A3 (en) 1996-06-27 2001-12-28 Smithkline Beecham Corp Il-8 receptor antagonists
KR20000022274A (ko) * 1996-06-27 2000-04-25 스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스 Il-8 수용체 길항제
SI0973735T1 (en) * 1997-04-10 2003-10-31 Pharmacia & Upjohn Company Polyaromatic antiviral compositions
US6060235A (en) * 1997-09-19 2000-05-09 Geltex Pharmaceuticals, Inc. Antiviral polymers comprising acid functional groups and hydrophobic groups
US6410255B1 (en) * 1999-05-05 2002-06-25 Aurora Biosciences Corporation Optical probes and assays
EP1591437B1 (de) 1999-05-14 2009-11-25 Nereus Pharmaceuticals, Inc. Interleukin-1 und Tumornekrosefaktor-alpha Modulatoren,Synthese dieser Modulatoren und Methoden zur Anwendung dieser Modulatoren
AU7353300A (en) * 1999-09-08 2001-04-10 Guilford Pharmaceuticals Inc. Non-peptidic cyclophilin binding compounds and their use
WO2001062919A1 (en) 2000-02-23 2001-08-30 Aurora Biosciences Corporation Modified fluorescent proteins
WO2002038140A2 (en) * 2000-11-09 2002-05-16 Contrimmune Biotechnology Inc Therapeutic uses for ip3 receptor-mediated calcium channel modulators
AU2002243228B2 (en) * 2000-11-16 2007-08-02 The Regents Of The University Of California Marine actinomycete taxon for drug and fermentation product discovery
MXPA03006666A (es) 2001-01-25 2004-05-31 Guilford Pharm Inc Compuestos de union de ciclofilina carbociclicos trisubstituidos y su uso.
US7176232B2 (en) 2002-06-24 2007-02-13 The Regents Of The University Of California Salinosporamides and methods for use thereof
AU2003296908A1 (en) * 2002-09-27 2004-05-04 Nereus Pharmaceuticals, Inc. Macrocyclic lactams
EP1638552B1 (de) * 2003-06-20 2011-03-02 Nereus Pharmaceuticals, Inc. Verwendung von (3.2.0) heterocyclischen verbindungen und ihren analoga zur behandlung von krebs
ZA200600473B (en) * 2003-06-20 2007-04-25 Univ California Salinosporamides and methods for use thereof
US7727752B2 (en) * 2003-07-29 2010-06-01 Life Technologies Corporation Kinase and phosphatase assays
CA2445420A1 (en) * 2003-07-29 2005-01-29 Invitrogen Corporation Kinase and phosphatase assays
US7619059B2 (en) * 2003-07-29 2009-11-17 Life Technologies Corporation Bimolecular optical probes
ATE509018T1 (de) * 2004-01-23 2011-05-15 Nereus Pharmaceuticals Inc Als antimikrobielle mittel geeignete bisindolpyrrole
AU2005283141B2 (en) 2004-04-30 2012-05-10 Nereus Pharmaceuticals, Inc. (3.2.0) heterocyclic compounds and methods of using the same
US7579371B2 (en) 2004-04-30 2009-08-25 Nereus Pharmaceuticals, Inc. Methods of using [3.2.0] heterocyclic compounds and analogs thereof
MY148329A (en) * 2004-07-05 2013-03-29 Malaysian Palm Oil Board A process for producing oligomers
WO2006060676A1 (en) 2004-12-03 2006-06-08 Dana Farber Cancer Institute Compositions and methods for treating neoplastic diseases
ATE556046T1 (de) 2005-07-21 2012-05-15 Nereus Pharmaceuticals Inc Interleukin-1- und tumornekrosefaktor-a- modulatoren, synthese solcher modulatoren und verfahren unter anwendung solcher modulatoren
WO2008095195A2 (en) * 2007-02-02 2008-08-07 Nereus Pharmaceuticals, Inc. Lyophilized formulations of salinosporamide a
US20090017167A1 (en) * 2007-07-11 2009-01-15 Herbalife International Inc. Mixture and beverage made therefrom for protecting cellular hydration
US8394816B2 (en) * 2007-12-07 2013-03-12 Irene Ghobrial Methods of using [3.2.0] heterocyclic compounds and analogs thereof in treating Waldenstrom's Macroglobulinemia
WO2009140287A1 (en) 2008-05-12 2009-11-19 Nereus Pharmaceuticals, Inc. Salinosporamide derivatives as proteasome inhibitors
EP2331655B1 (de) 2008-08-19 2013-07-03 Crysoptix K.K. Zusammensetzung aus organischen verbindungen, optischer film und herstellungsverfahren dafür
WO2012007923A1 (en) 2010-07-16 2012-01-19 Crysoptix Kk Optical retardation film and method of production thereof
CN102432871B (zh) * 2011-07-25 2014-03-26 中国科学院长春应用化学研究所 聚脲制备方法
EP2868709A1 (de) 2013-10-29 2015-05-06 DyStar Colours Distribution GmbH Metallfreie Säurefarbstoffe, Verfahren für ihre Herstellung und ihre Verwendung
BR112015029599A2 (pt) 2013-10-29 2017-07-25 Dystar Colours Distrib Gmbh tinturas ácidas, processo para a produção das mesmas e seu uso
EP2868715A1 (de) 2013-10-29 2015-05-06 DyStar Colours Distribution GmbH Metallfreie Säurefarbstoffe, Verfahren für ihre Herstellung und ihre Verwendung
EP2868713A1 (de) 2013-10-29 2015-05-06 DyStar Colours Distribution GmbH Metallfreie Säurefarbstoffe, Verfahren für ihre Herstellung und ihre Verwendung
EP2868705A1 (de) 2013-10-29 2015-05-06 DyStar Colours Distribution GmbH Metallfreie Säurefarbstoffe, Verfahren für ihre Herstellung und ihre Verwendung
EP2868707A1 (de) 2013-10-29 2015-05-06 DyStar Colours Distribution GmbH Metallfreie Säurefarbstoffe, Verfahren für ihre Herstellung und ihre Verwendung
EP2868703A1 (de) 2013-10-29 2015-05-06 DyStar Colours Distribution GmbH Metallfreie Säurefarbstoffe, Verfahren für ihre Herstellung und ihre Verwendung
EP2868711A1 (de) 2013-10-29 2015-05-06 DyStar Colours Distribution GmbH Metallfreie Säurefarbstoffe, Verfahren für ihre Herstellung und ihre Verwendung
EP2868708A1 (de) 2013-10-29 2015-05-06 DyStar Colours Distribution GmbH Metallfreie Säurefarbstoffe, Verfahren für ihre Herstellung und ihre Verwendung
EP3628640B1 (de) 2014-09-02 2023-08-09 Hub Therapeutics Verfahren zur herstellung eines deuterierten oder eines nichtdeuterierten moleküls und pharmazeutische formulierungen zur behandlung
US10751317B2 (en) 2014-10-08 2020-08-25 Pacific Northwest Research Institute Methods and compositions for increasing the potency of antifungal agents
EP3209760B1 (de) * 2014-10-20 2018-08-01 Henkel AG & Co. KGaA Farbschützendes waschmittel
US20170233682A1 (en) * 2014-10-21 2017-08-17 Henkel Ag & Co. Kgaa Anti-grey detergent
RU2635765C1 (ru) * 2016-10-31 2017-11-15 Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) Средство, обладающее противовирусной активностью в отношении вируса гриппа
KR101781809B1 (ko) * 2016-12-08 2017-09-27 주식회사 유니피에스 개인 휴대용 단말기의 보안관리용 비닐팩
MX2020010036A (es) 2018-03-28 2021-03-02 Herbalife Int Of America Inc Acetilacion de polisacaridos.
CN110078648B (zh) * 2019-04-25 2021-01-12 上海俪源科技有限公司 一种4,4’-二氨基二磺化二苯砜及其制备方法和应用
US20210330698A1 (en) * 2020-04-23 2021-10-28 Johnson & Johnson Consumer Inc. Methods and compositions for inhibiting enveloped viruses using low molecular weight hydrophobically modified polymers

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB781479A (en) * 1953-08-27 1957-08-21 Ciba Ltd New polyureas and process for making them
US2833744A (en) * 1953-08-27 1958-05-06 Ciba Pharm Prod Inc Polyureas and process of preparing same
DE1067212B (de) * 1956-06-04 1959-10-15 Farbenfabriken Bayer Aktiengesellschaft, Leverkusen-Bayerwerk Verfahren zur Herstellung von löslichen Polyharnstoffen
CH373467A (de) * 1957-12-23 1963-11-30 Siemens Ag Verfahren zur Prüfung der Beanspruchung von Wechselstromschaltgeräten beim Unterbrechen von Strömen und Anordnung zur Ausübung dieses Verfahrens
US3164571A (en) * 1959-12-31 1965-01-05 Union Carbide Corp Polyureas from n-phenyl, phenylene biscarbamyl halide and a diamine
BE660945A (de) * 1964-03-12 1965-07-01
US3528949A (en) * 1968-05-07 1970-09-15 Atlas Chem Ind Polymers from ureas and dihalides
FR2105446A5 (en) * 1970-09-07 1972-04-28 Inst Francais Du Petrole Polyamide-imide sulfones - used as cation exchangers and in varnish compsns
US4312855A (en) * 1970-11-16 1982-01-26 Colgate-Palmolive Company Compositions containing aminopolyureylene resin
DE2162963C3 (de) * 1971-12-18 1979-02-01 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von 1,4-Diaminobenzol-2,5-disulfonsäure
US3839294A (en) * 1972-05-01 1974-10-01 Du Pont Sulfonation of diamides of meta-phenylenediamine
FR2212356A1 (en) * 1972-12-29 1974-07-26 Inst Francais Du Petrole Sulphonated imide amide copolymers - used as films membranes, cationic varnishes, ion exchangers, in electrodialysis etc
US3993625A (en) * 1973-05-28 1976-11-23 Toray Industries, Inc. Permselective polymeric membranes of organic polyamide or polyhydrazide
US3978024A (en) * 1973-12-28 1976-08-31 General Electric Company Flame retardant polycarbonate composition
DE2516305A1 (de) * 1975-04-15 1976-10-28 Dynamit Nobel Ag Wasserdispergierbare esterharze
US4107202A (en) * 1977-03-28 1978-08-15 American Cyanamid Company Substituted 4,4'-biphenylylene bis(2-thioureylene)di-naphthalenetrisulfonic acids and salts thereof
GB2001054A (en) * 1977-07-01 1979-01-24 American Cyanamid Co Inhibitors for body fluid proteins
US4756907A (en) * 1978-10-17 1988-07-12 Stolle Research & Development Corp. Active/passive immunization of the internal female reproductive organs
US4389521A (en) * 1979-03-26 1983-06-21 Teijin Limited Process for preparing a cyclic amide polar solvent composition
JPS56147822A (en) * 1980-04-17 1981-11-17 Dainippon Ink & Chem Inc Preparation of novel water-soluble or water-dispersible polyester resin
US4328244A (en) * 1980-05-21 1982-05-04 The Dow Chemical Company Novel (((substituted-phenyl)methyl)amino)benzenesulfonic acids and pharmaceutically-acceptable salts thereof
US4349568A (en) * 1980-06-12 1982-09-14 The Dow Chemical Company Sulfur-substituted diphenyl ethers having antiviral activity
DE3026575A1 (de) * 1980-07-12 1982-02-04 Bayer Ag, 5090 Leverkusen Antitumoral wirkende mittel
US4435394A (en) * 1981-12-17 1984-03-06 Shionogi & Co., Ltd. 3-Sulfonamido-benzophenonimine derivatives useful for treating virus infections
US4471110A (en) * 1982-08-02 1984-09-11 E. I. Dupont De Nemours And Company Polyamide of disulfonated diamine and permselective membrane thereof
DE3345902A1 (de) * 1983-12-20 1985-08-29 Cassella Ag, 6000 Frankfurt In wasser loesliche polymischester, verfahren zu ihrer herstellung und ihre verwendung
US4863735A (en) * 1985-02-19 1989-09-05 Massachusetts Institute Of Technology Biodegradable polymeric drug delivery system with adjuvant activity
US4824916A (en) * 1985-03-15 1989-04-25 The Dow Chemical Company Water-insoluble, crosslinked, sulfonated aromatic polyamide
US4604404A (en) * 1985-04-03 1986-08-05 A. H. Robins Company, Inc. Antiviral sulfonated naphthalene formaldehyde condensation polymers
US4783446A (en) * 1985-11-22 1988-11-08 Neushul Mariculture Incorporated Method for the treatment of AIDS virus and other retroviruses
DE3601136A1 (de) * 1986-01-16 1987-07-23 Max Planck Gesellschaft Hemmstoffe der reversen transkriptase fuer prophylaxe und therapie von retrovirus-infektionen in saeugetieren
US4895660A (en) * 1986-07-14 1990-01-23 The Dow Chemical Company Water-soluble aromatic polyamides and polyureas
DE3626309A1 (de) * 1986-08-02 1988-02-18 Stockhausen Chem Fab Gmbh Antivirusmittel
US4897260A (en) * 1987-05-22 1990-01-30 The Rockefeller University Compositions that affect suppression of cutaneous delayed hypersensitivity and products including same
DE3744119A1 (de) * 1987-12-24 1989-07-06 Basf Ag Verwendung von polysulfatierten heparinen
ZA9094B (en) * 1989-01-11 1990-10-31 Merrell Dow Pharma Heparin fraction with anti-hiv activity
JPH0422772A (ja) * 1990-05-16 1992-01-27 Sanden Corp 容量可変型斜板式圧縮機及び斜板
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers
US5124149A (en) * 1990-11-07 1992-06-23 The United States Of America As Represented By The Secretary Of Agriculture Compositions and methods for biocontrol using fluorescent brighteners
FR2669535A1 (fr) * 1990-11-26 1992-05-29 Medgenix Group Sa Utilisation a titre de medicament de macromolecules polysulfonees.
ATE116637T1 (de) * 1991-02-05 1995-01-15 Merrell Dow Pharma Sulfonische stilbenderivate zur behandlung von viruserkrankungen.
US5424063A (en) * 1992-01-09 1995-06-13 The Dow Chemical Company Narrow poly- and mono-dispersed anionic oligomers, and their uses, formulations and process
KR100275843B1 (ko) * 1992-02-20 2000-12-15 슈테펜엘.네스비트 설폰산 유도체 및 이를 포함하는 약제학적 조성물
US5460807A (en) * 1992-08-19 1995-10-24 Merrell Dow Pharmaceuticals Inc. Antiproliferative oligomers
US5384119A (en) * 1993-08-12 1995-01-24 Merrell Dow Pharmaceuticals Inc. Method of preventing neutrophil mediated connective tissue damage

Also Published As

Publication number Publication date
CN1051096C (zh) 2000-04-05
NO930052D0 (no) 1993-01-08
DE69130381D1 (de) 1998-11-26
NO912672L (no) 1992-01-10
AU8286791A (en) 1992-02-04
JPH06500535A (ja) 1994-01-20
AU8024291A (en) 1992-01-09
MX9100123A (es) 1992-02-28
DK0538373T3 (da) 1998-10-12
US5707615A (en) 1998-01-13
EP0538373A4 (en) 1993-07-21
HU219229B (en) 2001-03-28
CA2086438A1 (en) 1992-01-10
ATE172477T1 (de) 1998-11-15
NO302827B1 (no) 1998-04-27
FI108041B (fi) 2001-11-15
KR920002662A (ko) 1992-02-28
PT98255A (pt) 1992-05-29
EP0538373B1 (de) 1998-05-13
CA2086438C (en) 2002-03-12
US5276182A (en) 1994-01-04
FI913298A0 (fi) 1991-07-08
HU912299D0 (en) 1991-12-30
HU9300038D0 (en) 1993-04-28
EP0467185B1 (de) 1998-10-21
HUT62621A (en) 1993-05-28
DK0467185T3 (da) 1999-06-28
EP0467185A3 (en) 1992-09-09
KR100212336B1 (ko) 1999-08-02
AP9100317A0 (en) 1991-10-31
AP287A (en) 1993-10-16
IE912375A1 (en) 1992-01-15
KR100208547B1 (ko) 1999-07-15
HU214876B (hu) 1998-07-28
DE69129410T2 (de) 1998-12-03
US5606108A (en) 1997-02-25
HK1009280A1 (en) 1999-05-28
HUT63561A (en) 1993-09-28
EG19652A (en) 1995-10-31
US5670143A (en) 1997-09-23
OA10045A (en) 1996-10-14
RU2102406C1 (ru) 1998-01-20
FI930066A (fi) 1993-01-08
FI913298A (fi) 1992-01-10
CA2046491A1 (en) 1992-01-10
ATE165974T1 (de) 1998-05-15
WO1992000749A1 (en) 1992-01-23
JP3187455B2 (ja) 2001-07-11
US6232349B1 (en) 2001-05-15
JPH04226521A (ja) 1992-08-17
EP0467185A2 (de) 1992-01-22
ES2116295T3 (es) 1998-07-16
CS212091A3 (en) 1992-10-14
US5547992A (en) 1996-08-20
DE69129410D1 (de) 1998-06-18
FI930066A0 (fi) 1993-01-08
AU635850B2 (en) 1993-04-01
US5571505A (en) 1996-11-05
US5728874A (en) 1998-03-17
NO930052L (no) 1993-03-09
IL98761A0 (en) 1992-07-15
AU650281B2 (en) 1994-06-16
NO912672D0 (no) 1991-07-08
ES2124695T3 (es) 1999-02-16
JP3442072B2 (ja) 2003-09-02
CN1058959A (zh) 1992-02-26
US5728731A (en) 1998-03-17
NZ238847A (en) 1994-12-22
CZ288574B6 (cs) 2001-07-11
EP0538373A1 (de) 1993-04-28
PT98255B (pt) 1998-12-31
IL98761A (en) 1995-03-30
SK283655B6 (sk) 2003-11-04

Similar Documents

Publication Publication Date Title
DE69130381D1 (de) Oligomere, ihre Verwendungen sowie Formulierungen
MX9203481A (es) Formulaciones.
DE69113962D1 (de) Maximalverhältnis-diversitykombinationstechnik.
DZ1835A1 (fr) Nouvelles formulations.
DE69306941D1 (de) Steuerknüppel.
FI934610A0 (fi) Ventilsammansaettning foer roerledning, omfattande loestagbart ventilsaete
DE59101488D1 (de) Schultergelenkbandage.
FI932516A (fi) Styrkonsol, i synnerhet foer motorfordon
FI931747A0 (fi) Reflexkropp, isynnerhet foer vaegmarkeringar
DK0811593T3 (da) 1,4-diaryl-2-flour-2-buten som insektcider og acaricider
FR2663550B1 (fr) Descendeur autobloquant.
FR2697998B1 (fr) Chevillère.
FR2689161B1 (fr) Echafaudage.
FI934317A (fi) Farmaceutiska sammansaettningar, vilka innehaoller ej-joniska ytaktiva aemnen
KR930703291A (ko) 치환된 피리딜피리미딘, 그의 제조방법 및 용도, 및 신규한 중간체
ATA12282000A (de) Galenische formulierungen
FI266U1 (fi) Kapningsanordning foer aemnesbana, saosom en pappersbana
FI935129A (fi) Tvaovaoningsgodsvagn, saerskilt foer biltransport
ZA915280B (en) Oligomers,their uses and formulations
IT232142Y1 (it) Bretelle per indumenti.
ITAV910001A0 (it) Brevetto "maria".
FI923688A0 (fi) Anordning/procedur ansaetta portomaerke.
DE58903461D1 (de) Polybutandiol(1,4)w,w'bismercaptane und ihre herstellung.
SE9200921L (sv) Madrass, eller liknande
FR2661444B1 (fr) Echafaudage.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee